Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07064174 · ClinicalTrials.gov registry record
Sickle Cell Kidney Biorepository
A clinical trial of Chronic Kidney Disease and Sickle Cell Trait, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 800
- Enrollment target
- 2
- Study locations
NCT07064174: Recruiting study of Chronic Kidney Disease and Sickle Cell Trait, sponsored by University of Texas Southwestern Medical Center.
NCT07064174 is a study of Chronic Kidney Disease and Sickle Cell Trait that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 800 participants, below the 3,199-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07064174, a study of Chronic Kidney Disease and Sickle Cell Trait, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 2
- Study locations
Study Summary
Kidney disease is a major cause of illness and death in people with sickle cell disease and sickle cell trait. Despite these concerning facts, we do not (1) have an in-depth understanding of how kidney disease starts in sickle cell disease and sickle cell trait, (2) have detailed insights into why kidney disease is worse in people with sickle cell disease and sickle cell trait, (3) have management options that are tailored to treating or preventing kidney disease in people with sickle cell disease or sickle cell trait. The SCeK Biorepository is a specialized, secure repository designed for the collection of blood and urine samples from people with sickle cell disease and sickle cell trait. These samples are connected to detailed medical records, with the sole purpose of allowing researchers to better understand how kidney disease starts and progresses in people with the sickle cell gene. By studying these stored samples (using new tests) together with health information, researchers can find better early warning signs of kidney injury and develop better ways to protect kidney health in people with sickle cell disease and sickle cell trait.
Primary Outcome
Mean change in the estimated glomerular filtration rate per year
Conditions Studied
Study Locations (2)
Texas
- Parkland Memorial Hospital - Dallas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2024-08-22 |
| Est. Completion | 2049-12 |
What NCT07064174 shows while recruiting
NCT07064174 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 3,199-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.
NCT07064174 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07064174 about?
NCT07064174 is a clinical study titled "Sickle Cell Kidney Biorepository". Kidney disease is a major cause of illness and death in people with sickle cell disease and sickle cell trait. Despite these concerning facts, we do not (1) have an in-depth understanding of how kidney disease starts in sickle cell disease and sickle cell trait, (2) have detailed insights into why k...
What is the current status of trial NCT07064174?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2024-08-22. Estimated completion is 2049-12.
What conditions does trial NCT07064174 study?
This clinical trial studies the following conditions: Chronic Kidney Disease, Sickle Cell Trait, Sickle Cell Disease (SCD).
Who is sponsoring clinical trial NCT07064174?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07064174 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07064174's enrollment target sits among peer trials
800 20th of 101 higher than 82 of 101 other Chronic Kidney Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
RECRUITING · Phase 2
-
Patient-driven Management of BP in CKD
RECRUITING · Phase 3
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Safety of Short-course of NSAIDs in Pediatric Patients With CKD
RECRUITING · Phase 4
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI